Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
